高度近视后巩膜收缩术后近视性黄斑病变进展的发生率及相关因素
这项来自三级医院的回溯性队列研究纳入892眼(892例)等效球镜≤-6.00D且接受后巩膜收缩术的高度近视患者,用ATN系统分级黄斑病变。中位随访13.57个月期间10.76%眼出现ATN进展,1、3、5年无进展累积生存率分别为94.57%、86.44%、76.22%。基线更陡的K2和更高眼压是进展的显著相关因素。
要点
- 后巩膜收缩术后中位随访13.57个月,10.76%眼出现基于ATN系统的近视性黄斑病变进展。
- 无ATN进展的累积生存率:1年94.57%、3年86.44%、5年76.22%。
- 基线眼压较高与萎缩进展风险相关(HR 1.138,P=0.030),基线更陡K2是牵引和新生血管进展的危险因素。
核心结论
- 后巩膜收缩术虽显著改善高度近视患者等效球镜和眼轴,但近视性黄斑病变仍不可避免地进展。
- 基线更陡的K2和更高眼压是进展的显著相关因素。
- 这些发现提示近视性黄斑病变进展存在力学生物学机制,并指向潜在预防策略。
研究设计与样本
- 来自三级医院的回溯性队列研究,纳入温州医科大学附属眼视光医院屈光手术临床中心接受后巩膜收缩术、等效球镜≤-6.00D的892眼(892例)。
- 基于眼底照相和OCT图像,采用更新的萎缩-牵引-新生血管(ATN)系统对近视性黄斑病变进行分级。
- 以任一ATN组分评分增加定义进展,采用Kaplan-Meier分析评估,并用Cox回归评估萎缩、牵引和新生血管进展的预测因素。
主要发现
- 后巩膜收缩术在未进展者中显著改善最佳矫正视力、等效球镜、眼轴、眼压和牵引评分。
- 中位随访13.57个月期间,10.76%眼出现ATN进展;无ATN进展的累积生存率1年为94.57%、3年为86.44%、5年为76.22%。
- 对于萎缩进展,基线A1至A3组分具有保护作用,而较高眼压增加风险(HR 1.138,P=0.030)。
- 对于牵引进展,基线T2至T3具有保护作用,而基线更陡的陡峭角膜曲率(K2)是危险因素(HR 1.183,P=0.026)。
- 基线T5和更陡K2强烈预测新生血管进展(HR分别为10.773[P=0.004]和1.439[P=0.003])。
关键数值与推荐
- 近视性黄斑病变进展定义为任一ATN组分评分增加。
- 无ATN进展累积生存率:1年94.57%、3年86.44%、5年76.22%。
- 萎缩进展:基线A1至A3保护,较高眼压HR 1.138(P=0.030)。
- 牵引进展:基线T2至T3保护,更陡K2的HR 1.183(P=0.026)。
- 新生血管进展:基线T5的HR 10.773(P=0.004),更陡K2的HR 1.439(P=0.003)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To explore the progression predictors of myopic maculopathy in patients with high myopia after posterior scleral contraction (PSC). DESIGN: Retrospective cohort study from a tertiary hospital. PARTICIPANTS: A total of 892 eyes from 892 patients with a spherical equivalent (SE) of -6.00 diopters or less who underwent PSC at the Refractive Surgery Clinical Center, Eye Hospital, Wenzhou Medical University, were included. METHODS: Myopic maculopathy was classified using the updated Atrophy-Traction-Neovascularization (ATN) system based on fundus photographs and OCT images. Progression, defined as an increase in any ATN component score, was assessed using Kaplan-Meier analysis. Predictors of atrophy, traction, and neovascularization progression were evaluated with Cox regression. MAIN OUTCOME MEASURES: Cumulative survival rates and predictors for the progression of myopic maculopathy. RESULTS: Posterior scleral contraction significantly improved best-corrected visual acuity, SE, axial length (AL), intraocular pressure (IOP), and traction scores in those without progression. However, 10.76% of eyes showed ATN progression over a median follow-up of 13.57 months, and the cumulative survival rates for patients with high myopia free of ATN progression were 94.57% at 1 year, 86.44% at 3 years, and 76.22% at 5 years after surgery. For atrophy progression, baseline A1 through A3 components were protective, whereas higher IOP increased risk (hazard ratio [HR], 1.138; P = 0.030). Baseline T2 through T3 were protective for traction progression, whereas steeper baseline steep keratometry (K2) was a risk factor (HR, 1.183; P = 0.026). Baseline T5 and steeper K2 strongly predicted neovascularization progression (HR, 10.773 [P = 0.004] and 1.439 [P = 0.003], respectively). CONCLUSIONS: Although PSC significantly improves SE and AL in patients with high myopia, myopic maculopathy inevitably progresses. Baseline steeper K2 and higher IOP are significant associated factors for progression. These findings suggest a mechanobiological mechanism underlying the progression of myopic maculopathy and point to potential preventive strategies. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
引用
- Zhao J, Zhao X, Jiang Y, et al. Incidence and Associated Factors of Myopic Maculopathy Progression after Posterior Scleral Contraction in High Myopia. Ophthalmology. 2025. PMID: 41260399. doi:10.1016/j.ophtha.2025.11.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。